Showing results (51-60 of 120) with videos related to

Sort By:
Pageof 12
Thorax|April 1, 1982
Shrinking pleuritis with atelectasisL Dernevik, P Gatzinsky, E Hultman, et al.
British Journal of Haematology|October 23, 1997
An alternative to continuous subcutaneous infusion of desferrioxamine in thalassaemic patientsF Di Gregorio, M A Romeo, G Pizzarelli, et al.
British Journal of Haematology|November 1, 1979
Alpha thalassaemia in Sicily: haematological and biosynthetic studiesS Musumeci, G Schiliro, G Pizzarelli, et al.
Scandinavian Journal of Thoracic and Cardiovascular Surgery|January 1, 1993
Effect of reduced aprotinin dosage on blood loss and use of blood products in patients undergoing cardiopulmonary bypassB Liu, A Belboul, G Rådberg, et al.
The Annals of Thoracic Surgery|June 1, 1995
Half-dose aprotinin preserves hemostatic function in patients undergoing bypass operationsB Liu, L Tengborn, G Larson, et al.
Pacing and Clinical Electrophysiology : PACE|November 24, 1998
Full ventricular capture indicated by the QT interval functionC Gottfridsson, I Wallentin, L Dernevik, et al.
Chinese Medical Journal|December 1, 1991
High-dose aprotinin (trasylol) in reducing bleeding and protecting lung function in potential bleeders undergoing cardiopulmonary bypassB Liu, A Belboul, N al-Khaja, et al.
European Journal of Respiratory Diseases|February 1, 1985
Immunological abnormalities in shrinking pleuritis with atelectasisL Dernevik, J Björkander, L A Hanson, et al.
Coronary Artery Disease|August 1, 1996
Half-dose aprotinin does not affect haemorheological properties in patients undergoing bypass surgeryB Liu, A Belboul, G Rådberg, et al.
The Thoracic and Cardiovascular Surgeon|December 1, 1988
Enzymatic activities in heart and skeletal muscle of children with cyanotic and noncyanotic congenital heart diseaseL Dernevik, A C Bylund-Fellenius, R Ekroth, et al.
Pageof 12